Glycolysis inhibition for anticancer treatment
暂无分享,去创建一个
H. Pelicano | P. Huang | D. Martin | Peng Huang | R. Xu | R-H Xu | H Pelicano | P Huang | D S Martin
[1] C. Rudin,et al. Bcl-xL and Akt cooperate to promote leukemogenesis in vivo , 2003, Oncogene.
[2] J. Koutcher,et al. A concomitant ATP-depleting strategy markedly enhances anticancer agent activity , 2001, Apoptosis.
[3] G. Giaccone,et al. Glufosfamide administered by 1-hour infusion as a second-line treatment for advanced non-small cell lung cancer; a phase II trial of the EORTC-New Drug Development Group. , 2004, European Journal of Cancer.
[4] Paolo Carlini,et al. Lonidamine: efficacy and safety in clinical trials for the treatment of solid tumors. , 2003, Drugs of today.
[5] M. Guida,et al. Paclitaxel, cisplatin and lonidamine in advanced ovarian cancer. A phase II study. , 2001, European journal of cancer.
[6] K. Williams,et al. Identification of a nucleic acid helix-destabilizing protein from rat liver as lactate dehydrogenase-5. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[7] M Cascante,et al. The effect of thiamine supplementation on tumour proliferation. A metabolic control analysis study. , 2001, European journal of biochemistry.
[8] W. Lieberthal,et al. Graded ATP depletion can cause necrosis or apoptosis of cultured mouse proximal tubular cells. , 1998, American journal of physiology. Renal physiology.
[9] P. Herrero,et al. The hexokinase 2 protein regulates the expression of the GLK1, HXK1 and HXK2 genes of Saccharomyces cerevisiae. , 2001, The Biochemical journal.
[10] L. Boros,et al. Detection of Resistance to Imatinib by Metabolic Profiling , 2005, American journal of pharmacogenomics : genomics-related research in drug development and clinical practice.
[11] N. Savaraj,et al. 2-Deoxy-d-glucose Increases the Efficacy of Adriamycin and Paclitaxel in Human Osteosarcoma and Non-Small Cell Lung Cancers In Vivo , 2004, Cancer Research.
[12] S. Schreiber,et al. Perturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[13] M. Perucho,et al. Study of the interaction of glyceraldehyde-3-phosphate dehydrogenase with DNA. , 1980, Biochimica et biophysica acta.
[14] Amy S. Lee,et al. The glucose-regulated proteins (GRP78 and GRP94): functions, gene regulation, and applications. , 1994, Critical reviews in eukaryotic gene expression.
[15] S. Bessman,et al. Hexokinase Binding to Mitochondria: A Basis for Proliferative Energy Metabolism , 1997, Journal of bioenergetics and biomembranes.
[16] A. Cattaneo,et al. Nuclear localization of a lactic dehydrogenase with single-stranded DNA-binding properties. , 1985, Experimental cell research.
[17] M. Sirover. New nuclear functions of the glycolytic protein, glyceraldehyde‐3‐phosphate dehydrogenase, in mammalian cells , 2005, Journal of cellular biochemistry.
[18] P. Natali,et al. Inhibition of aerobic glycolysis in normal and neoplastic lymphoid cells induced by Lonidamine [1-(2,4-dichlorobenzyl)-I-H-indazol-3-carboxylic acid]. , 1984, Oncology.
[19] N. Savaraj,et al. Hypoxia increases tumor cell sensitivity to glycolytic inhibitors: a strategy for solid tumor therapy (Model C). , 2002, Biochemical pharmacology.
[20] V. Bakanauskas,et al. Effect of oncogene transformation of rat embryo cells on cellular oxygen consumption and glycolysis. , 1997, Biochemical and biophysical research communications.
[21] M. Birnbaum,et al. Expression of a Constitutively Active Akt Ser/Thr Kinase in 3T3-L1 Adipocytes Stimulates Glucose Uptake and Glucose Transporter 4 Translocation* , 1996, The Journal of Biological Chemistry.
[22] D. Evans,et al. Germline SDHD mutation in familial phaeochromocytoma , 2001, The Lancet.
[23] D. Chuang,et al. Glyceraldehyde-3-phosphate dehydrogenase antisense oligodeoxynucleotides protect against cytosine arabinonucleoside-induced apoptosis in cultured cerebellar neurons. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[24] B. Teicher,et al. Effect of lonidamine on the cytotoxicity of four alkylating agents in vitro , 2004, Cancer Chemotherapy and Pharmacology.
[25] N. Hay,et al. Increased Hexokinase Activity, of Either Ectopic or Endogenous Origin, Protects Renal Epithelial Cells against Acute Oxidant-induced Cell Death* , 2002, The Journal of Biological Chemistry.
[26] E. Rozengurt,et al. Oxidative Stress Induces Protein Kinase D Activation in Intact Cells , 2000, The Journal of Biological Chemistry.
[27] L. Cantley,et al. Activation of phosphatidylinositol 3-kinase by insulin. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[28] David G. Watson,et al. Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. , 2005, Cancer cell.
[29] H. T. Kang,et al. 2-Deoxyglucose: an anticancer and antiviral therapeutic, but not any more a low glucose mimetic. , 2006, Life sciences.
[30] Jan B Hoek,et al. Hexokinase II: the integration of energy metabolism and control of apoptosis. , 2003, Current medicinal chemistry.
[31] H. Koepsell,et al. Transport of the new chemotherapeutic agent beta-D-glucosylisophosphoramide mustard (D-19575) into tumor cells is mediated by the Na+-D-glucose cotransporter SAAT1. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[32] A. Cornish-Bowden,et al. Evolution and regulatory role of the hexokinases. , 1998, Biochimica et biophysica acta.
[33] W. Zong,et al. Alkylating DNA damage stimulates a regulated form of necrotic cell death. , 2004, Genes & development.
[34] R. Roeder,et al. S Phase Activation of the Histone H2B Promoter by OCA-S, a Coactivator Complex that Contains GAPDH as a Key Component , 2003, Cell.
[35] K. Entian,et al. Characterization of Hex2 protein, a negative regulatory element necessary for glucose repression in yeast. , 1991, European journal of biochemistry.
[36] H. W. van den Berg,et al. The anti-proliferative effects of tyrosine kinase inhibitors towards tamoxifen-sensitive and tamoxifen-resistant human breast cancer cell lines in relation to the expression of epidermal growth factor receptors (EGF-R) and the inhibition of EGF-R tyrosine kinase. , 1999, Cancer letters.
[37] N. Hay,et al. Akt Inhibits Apoptosis Downstream of BID Cleavage via a Glucose-Dependent Mechanism Involving Mitochondrial Hexokinases , 2004, Molecular and Cellular Biology.
[38] W. Ford,et al. Glycolysis and sperm motility: does a spoonful of sugar help the flagellum go round? , 2006, Human reproduction update.
[39] E. Sauter,et al. Mitochondrial DNA mutations in breast cancer tissue and in matched nipple aspirate fluid. , 2004, Carcinogenesis.
[40] J. Halter,et al. Caloric restriction mimetics: metabolic interventions. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.
[41] Peng Huang,et al. Mitochondrial DNA mutations in primary leukemia cells after chemotherapy: clinical significance and therapeutic implications , 2003, Leukemia.
[42] A. Quintana,et al. Metallothionein prevents neurodegeneration and central nervous system cell death after treatment with gliotoxin 6‐aminonicotinamide , 2004, Journal of neuroscience research.
[43] M. Yamada,et al. Over-expression of GAPDH induces apoptosis in COS-7 cells transfected with cloned GAPDH cDNAs. , 1999, Neuroreport.
[44] B. Dutrillaux,et al. Phase II Study of Lonidamine and Diazepam in the Treatment of Recurrent Glioblastoma Multiforme , 2003, Journal of Neuro-Oncology.
[45] J. Pouysségur,et al. The hypoxia-inducible factor and tumor progression along the angiogenic pathway. , 2005, International review of cytology.
[46] A. Alavi,et al. Akt Stimulates Aerobic Glycolysis in Cancer Cells , 2004, Cancer Research.
[47] R. Lynch,et al. Modulation of hexokinase association with mitochondria analyzed with quantitative three-dimensional confocal microscopy , 1991, The Journal of cell biology.
[48] I. Weber,et al. Sugar specificity of human beta-cell glucokinase: correlation of molecular models with kinetic measurements. , 1995, Biochemistry.
[49] Peng Huang,et al. Mitochondrial defects in cancer , 2002, Molecular Cancer.
[50] Otto Warburn,et al. THE METABOLISM OF TUMORS , 1931 .
[51] J. Hamada,et al. Hypoxia enhances the expression of autocrine motility factor and the motility of human pancreatic cancer cells , 2002, British Journal of Cancer.
[52] C. Sander,et al. Convergent evolution of similar enzymatic function on different protein folds: The hexokinase, ribokinase, and galactokinase families of sugar kinases , 1993, Protein science : a publication of the Protein Society.
[53] Hong-yu Yang,et al. Mutation in D-loop region of mitochondrial DNA in gastric cancer and its significance. , 2005, World journal of gastroenterology.
[54] B. Burgering,et al. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction , 1995, Nature.
[55] C. Boschek,et al. Pyruvate kinase type M2 and its role in tumor growth and spreading. , 2005, Seminars in cancer biology.
[56] Awtar Krishan,et al. Greater cell cycle inhibition and cytotoxicity induced by 2-deoxy-d-glucose in tumor cells treated under hypoxic vs aerobic conditions , 2004, Cancer Chemotherapy and Pharmacology.
[57] R. Molina,et al. Serum phosphohexose isomerase activities in patients with colorectal cancer. , 1991, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.
[58] H. Lodish,et al. Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes. , 1987, Science.
[59] Saroj P. Mathupala,et al. Glucose Catabolism in Cancer Cells , 1997, The Journal of Biological Chemistry.
[60] E. Kandel,et al. Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. , 2001, Genes & development.
[61] P. Pedersen,et al. High aerobic glycolysis of rat hepatoma cells in culture: role of mitochondrial hexokinase. , 1977, Proceedings of the National Academy of Sciences of the United States of America.
[62] L. Forman,et al. Glucosephosphate isomerase (GPI) deficiency mutations associated with hereditary nonspherocytic hemolytic anemia (HNSHA). , 1997, Blood cells, molecules & diseases.
[63] F. Goodwin,et al. FUNCTIONAL PROPERTIES OF NEURONAL AND GLIAL ISOENZYMES OF BRAIN ENOLASE , 1978, Journal of neurochemistry.
[64] Peter Devilee,et al. The SDH mutation database: an online resource for succinate dehydrogenase sequence variants involved in pheochromocytoma, paraganglioma and mitochondrial complex II deficiency , 2005, BMC Medical Genetics.
[65] R. Harrison. The detection of hexokinase, glucosephosphate isomerase and phosphoglucomutase activities in polyacrylamide gels after electrophoresis: a novel method using immobilized glucose 6-phosphate dehydrogenase. , 1974, Analytical biochemistry.
[66] C. Martínez-Campa,et al. Transcriptional regulation of the Saccharomyces cerevisiae HXK1, HXK2 and GLK1 genes , 1995, Yeast.
[67] B. Dwarakanath,et al. Radiosensitization by 6-aminonicotinamide and 2-deoxy-D-glucose in human cancer cells , 2005, International journal of radiation biology.
[68] M. Guppy,et al. Cancer metabolism: facts, fantasy, and fiction. , 2004, Biochemical and biophysical research communications.
[69] A. Raz,et al. Tumor autocrine motility factor is an angiogenic factor that stimulates endothelial cell motility. , 2001, Biochemical and biophysical research communications.
[70] P. Pedersen,et al. Recently elucidated energy catabolism pathways provide opportunities for novel treatments in hepatocellular carcinoma , 2004, Expert review of anticancer therapy.
[71] R. Passantino,et al. ENO1 gene product binds to the c‐myc promoter and acts as a transcriptional repressor: relationship with Myc promoter‐binding protein 1 (MBP‐1) , 2000, FEBS letters.
[72] D. Vertommen,et al. Phosphorylation and Activation of Heart 6-Phosphofructo-2-kinase by Protein Kinase B and Other Protein Kinases of the Insulin Signaling Cascades* , 1997, The Journal of Biological Chemistry.
[73] H. Neumann,et al. Mutations of the SDHB and SDHD genes , 2004, Familial Cancer.
[74] K. Brand,et al. The diagnostic validity of the serum tumor marker phosphohexose isomerase (PHI) in patients with gastrointestinal, kidney, and breast cancer. , 1990, Cancer investigation.
[75] Zhuchu Chen,et al. Proteome analysis of human lung squamous carcinoma , 2006, Proteomics.
[76] S. R. Datta,et al. BAD and glucokinase reside in a mitochondrial complex that integrates glycolysis and apoptosis , 2003, Nature.
[77] S. Gottschalk,et al. Imatinib (STI571)-Mediated Changes in Glucose Metabolism in Human Leukemia BCR-ABL-Positive Cells , 2004, Clinical Cancer Research.
[78] Martin G Pomper,et al. Advanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATP. , 2004, Biochemical and biophysical research communications.
[79] Hiroshi Yamamoto,et al. Expression of autocrine motility factor receptor correlates with disease progression in human gastric cancer. , 1996, British Journal of Cancer.
[80] G. Blackburn,et al. Soybean phytochemicals inhibit the growth of transplantable human prostate carcinoma and tumor angiogenesis in mice. , 1999, The Journal of nutrition.
[81] N. Savaraj,et al. Hypersensitization of tumor cells to glycolytic inhibitors. , 2001, Biochemistry.
[82] D. Lacombe,et al. Glufosfamide administered using a 1-hour infusion given as first-line treatment for advanced pancreatic cancer. A phase II trial of the EORTC-new drug development group. , 2003, European journal of cancer.
[83] A. López-Rivas,et al. Inhibition of Glucose Metabolism Sensitizes Tumor Cells to Death Receptor-triggered Apoptosis through Enhancement of Death-inducing Signaling Complex Formation and Apical Procaspase-8 Processing* , 2003, The Journal of Biological Chemistry.
[84] S. Sealfon,et al. Nuclear translocation of GAPDH-GFP fusion protein during apoptosis. , 1999, Neuroreport.
[85] Peng Huang,et al. ROS stress in cancer cells and therapeutic implications. , 2004, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[86] O. Warburg. [Origin of cancer cells]. , 1956, Oncologia.
[87] L. Tretter,et al. Alpha-ketoglutarate dehydrogenase: a target and generator of oxidative stress , 2005, Philosophical Transactions of the Royal Society B: Biological Sciences.
[88] M. Cascante,et al. Oxythiamine and dehydroepiandrosterone induce a G1 phase cycle arrest in Ehrlich's tumor cells through inhibition of the pentose cycle , 1999, FEBS letters.
[89] Robert W. Taylor,et al. Mitochondrial DNA mutations in human disease , 2005, Nature Reviews Genetics.
[90] D. McInnis,et al. Improving Male Mating Competitiveness and Survival in the Field for Medfly, Ceratitis Capitata(Diptera: Tephritidae) SIT Programs , 2002, Genetica.
[91] R. Gillies,et al. Why do cancers have high aerobic glycolysis? , 2004, Nature Reviews Cancer.
[92] C. Eng,et al. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. , 2004, JAMA.
[93] D. Chuang,et al. Glyceraldehyde-3-phosphate dehydrogenase, apoptosis, and neurodegenerative diseases. , 2005, Annual review of pharmacology and toxicology.
[94] A. Garg,et al. Chemosensitization and radiosensitization of tumors by plant polyphenols. , 2005, Antioxidants & redox signaling.
[95] H. Koepsell,et al. Mechanistic aspects of the cytotoxic activity of glufosfamide, a new tumour therapeutic agent , 2000, British Journal of Cancer.
[96] S. Sternberg,et al. Biochemical modulation of tumor cell energy in vivo: II. A lower dose of adriamycin is required and a greater antitumor activity is induced when cellular energy is depressed. , 1994, Cancer investigation.
[97] Yiwei Li,et al. Genistein-induced G2-M arrest, p21WAF1 upregulation, and apoptosis in a non-small-cell lung cancer cell line. , 1998, Nutrition and cancer.
[98] P. Pedersen,et al. Glucose catabolism in the rabbit VX2 tumor model for liver cancer: characterization and targeting hexokinase. , 2001, Cancer letters.
[99] M. Laakso,et al. Analysis of the human hexokinase II promoter in vivo: lack of insulin response within 4.0 kb. , 2004, Biochimica et biophysica acta.
[100] John Eric Wilson. Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function , 2003, Journal of Experimental Biology.
[101] M. Miller,et al. alpha-Chlorohydrin inhibits glyceraldehyde-3-phosphate dehydrogenase in multiple organs as well as in sperm. , 2001, Toxicological sciences : an official journal of the Society of Toxicology.
[102] Keshav K. Singh. Mitochondrial Dysfunction Is a Common Phenotype in Aging and Cancer , 2004, Annals of the New York Academy of Sciences.
[103] E. Warburg. Kritisches zu der Arbeit des Herrn W. Th. Anderson jr., The photolysis of potassium nitrate solutions , 1924 .
[104] Saroj P. Mathupala,et al. Aberrant Glycolytic Metabolism of Cancer Cells: A Remarkable Coordination of Genetic, Transcriptional, Post-translational, and Mutational Events That Lead to a Critical Role for Type II Hexokinase , 1997, Journal of bioenergetics and biomembranes.
[105] P. Hammerman,et al. Akt-Directed Glucose Metabolism Can Prevent Bax Conformation Change and Promote Growth Factor-Independent Survival , 2003, Molecular and Cellular Biology.
[106] S. Di Cosimo,et al. Addition of either lonidamine or granulocyte colony-stimulating factor does not improve survival in early breast cancer patients treated with high-dose epirubicin and cyclophosphamide. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[107] E. Van Schaftingen,et al. Purification and properties of phosphofructokinase 2/fructose 2,6-bisphosphatase from chicken liver and from pigeon muscle. , 1986, European journal of biochemistry.
[108] L. Boros,et al. Genistein Inhibits Nonoxidative Ribose Synthesis in MIA Pancreatic Adenocarcinoma Cells: A New Mechanism of Controlling Tumor Growth , 2001, Pancreas.
[109] O. Hankinson,et al. Identification of genes differentially induced by hypoxia in pancreatic cancer cells. , 2001, Biochemical and biophysical research communications.
[110] A. R. Jones,et al. Metabolism of 36Cl-ornidazole after oral application to the male rat in relation to its antifertility activity. , 1997, Xenobiotica; the fate of foreign compounds in biological systems.
[111] Daniel S. Martin,et al. Marked enhancement in vivo of paclitaxel's (taxol's) tumor-regressing activity by ATP-depleting modulation , 1996, Anti-cancer drugs.
[112] L. Liotta,et al. Tumor cell autocrine motility factor. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[113] K. Wirtz,et al. "Wages of fear": transient threefold decrease in intracellular ATP level imposes apoptosis. , 2004, Biochimica et biophysica acta.
[114] A. Raz,et al. Autocrine motility factor secreted by tumor cells upregulates vascular endothelial growth factor receptor (Flt‐1) expression in endothelial cells , 2002, International journal of cancer.
[115] I. Tomlinson,et al. The TCA cycle and tumorigenesis: the examples of fumarate hydratase and succinate dehydrogenase , 2003, Annals of medicine.
[116] R. Lightowlers,et al. Identification of the NAD(+)-binding fold of glyceraldehyde-3-phosphate dehydrogenase as a novel RNA-binding domain. , 2000, Biochemical and biophysical research communications.
[117] F. Grosse,et al. Lactate dehydrogenase and glyceraldehyde-phosphate dehydrogenase are single-stranded DNA-binding proteins that affect the DNA-polymerase-alpha-primase complex. , 1986, European journal of biochemistry.
[118] T. Bruno,et al. Enhancement of doxorubicin content by the antitumor drug lonidamine in resistant Ehrlich ascites tumor cells through modulation of energy metabolism. , 1998, Biochemical pharmacology.
[119] H. Pelicano,et al. Synergistic effect of targeting mTOR by rapamycin and depleting ATP by inhibition of glycolysis in lymphoma and leukemia cells , 2005, Leukemia.
[120] Y. J. Sun,et al. The crystal structure of a multifunctional protein: phosphoglucose isomerase/autocrine motility factor/neuroleukin. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[121] Junjian Z. Chen,et al. Mitochondrial Mutagenesis and Oxidative Stress in Human Prostate Cancer , 2004, Journal of environmental science and health. Part C, Environmental carcinogenesis & ecotoxicology reviews.
[122] J. Hoek,et al. Mitochondrial Binding of Hexokinase II Inhibits Bax-induced Cytochrome c Release and Apoptosis* , 2002, The Journal of Biological Chemistry.